Previous 10 | Next 10 |
Agile Therapeutics ( AGRX ) -16% . Bed Bath & Beyond ( BBBY ) -13% on Q1 earnings release . Barnes & Noble Education ( BNED ) -15% on Q4 earnings release . Himax Technologies ( HIMX ) -12% . AeroVironment ( AVAV ) -...
Gainers: Endo International plc (ENDP) +95%. Agile Therapeutics (AGRX) +66%. Kezar Life Sciences (KZR) +53%. Decibel Therapeutics (DBTX) +25%. Ceragon Networks (CRNT) +23%. InflaRx (IFRX) +20%. Sutro Biopharma (STRO) +19%. Tyra Biosciences (TYRA) +17%. Oasis Petroleum (OAS) +16%. Biotricity (...
Gainers: Agile Therapeutics (AGRX) +81%. Kezar Life Sciences (KZR) +75%. Decibel Therapeutics (DBTX) +21%. Sutro Biopharma (STRO) +16%. Bellerophon Therapeutics (BLPH) +11%. Losers: Scholar Rock (SRRK) -11%. NGM Biopharmaceuticals (NGM)...
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Kezar Life Sciences (NASDAQ: KZR), Nova Mentis Life Sciences (OTC: NMLSF), Agile Therapeutics (NAS...
Kezar Life Sciences (KZR) +93% after mid-stage data for lupus nephritis candidate. Agile Therapeutics (AGRX) +46%. Evofem Biosciences (EVFM) +33% collaboration for birth control method. InflaRx (IFRX) +17% on vilobelimab getting FDA orphan drug status for skin disorder. Ce...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: oneinchpunch/Shutterstock.com It’s time for another dive into the biggest pre-market stock movers as we go over the news for Tuesday morning! We’ve got clinical trials, collaboration agreements...
Buying Penny Stocks on June 28th? Here’s What You Need to Know Finding penny stocks that are worth buying can be challenging. And despite there being a lot of positive movement in the past few trading days, the overall characterization of the stock market right now is bearish. Th...
Gainers: NeuroSense Therapeutics NRSN +83%. Axsome Therapeutics (AXSM) +37%. Agile Therapeutics (AGRX) +31%. GreenLight Biosciences (GRNA) +26%. Femasys (FEMY) +11%. Losers: GeoVax Labs GOVX -14%. SIGA Technologies (SIGA) -14%. Eargo (EAR) -12%. BioAtla...
There are plenty of catalysts in the stock market this week that could impact the future of investors for the rest of 2022. Critical economic data will be a bellwether for the next move. In the meantime, there’s likely to be no shortage of stock market volatility. This is where penny...
Axsome Therapeutics (AXSM) +50%as FDA issues proposed labeling for depression drug. Agile Therapeutics (AGRX) +42%. Nutex Health (NUTX) +14%announces that it has been selected to join both the RUSSELL 2000® AND RUSSELL 3000® INDEXES. Femasys (FEMY) +16%. Siyata Mobile (SYTA) +1...
News, Short Squeeze, Breakout and More Instantly...
Agile Therapeutics Inc. Company Name:
AGRX Stock Symbol:
NASDAQ Market:
Agile Therapeutics Inc. Website:
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare com...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2...